KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Operating Expenses: 2019-2024

Historic Operating Expenses for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to $786.8 million.

  • Ginkgo Bioworks Holdings' Operating Expenses fell 10.67% to $128.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $528.7 million, marking a year-over-year decrease of 37.96%. This contributed to the annual value of $786.8 million for FY2024, which is 29.49% down from last year.
  • As of FY2024, Ginkgo Bioworks Holdings' Operating Expenses stood at $786.8 million, which was down 29.49% from $1.1 billion recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Operating Expenses ranged from a high of $2.7 billion in FY2022 and a low of $213.7 million during FY2020.
  • Moreover, its 3-year median value for Operating Expenses was $1.1 billion (2023), whereas its average is $1.5 billion.
  • In the last 5 years, Ginkgo Bioworks Holdings' Operating Expenses surged by 902.56% in 2021 and then crashed by 58.47% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Operating Expenses stood at $213.7 million in 2020, then soared by 902.56% to $2.1 billion in 2021, then climbed by 25.41% to $2.7 billion in 2022, then plummeted by 58.47% to $1.1 billion in 2023, then fell by 29.49% to $786.8 million in 2024.